rs1383180

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_153717.3(EVC):​c.1727G>A​(p.Arg576Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.346 in 1,613,550 control chromosomes in the GnomAD database, including 99,274 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R576L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.32 ( 8380 hom., cov: 32)
Exomes 𝑓: 0.35 ( 90894 hom. )

Consequence

EVC
NM_153717.3 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.16

Publications

38 publications found
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028758347).
BP6
Variant 4-5783715-G-A is Benign according to our data. Variant chr4-5783715-G-A is described in ClinVar as Benign. ClinVar VariationId is 262768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.1727G>A p.Arg576Gln missense_variant Exon 12 of 21 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.1727G>A p.Arg576Gln missense_variant Exon 12 of 21 1 NM_153717.3 ENSP00000264956.6 P57679
CRMP1ENST00000506216.5 linkn.1648-35403C>T intron_variant Intron 12 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.321
AC:
48777
AN:
151962
Hom.:
8380
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.204
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.389
Gnomad EAS
AF:
0.316
Gnomad SAS
AF:
0.227
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.338
GnomAD2 exomes
AF:
0.349
AC:
87463
AN:
250448
AF XY:
0.342
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.493
Gnomad ASJ exome
AF:
0.381
Gnomad EAS exome
AF:
0.310
Gnomad FIN exome
AF:
0.339
Gnomad NFE exome
AF:
0.367
Gnomad OTH exome
AF:
0.364
GnomAD4 exome
AF:
0.349
AC:
509331
AN:
1461470
Hom.:
90894
Cov.:
54
AF XY:
0.345
AC XY:
250549
AN XY:
727026
show subpopulations
African (AFR)
AF:
0.188
AC:
6276
AN:
33470
American (AMR)
AF:
0.488
AC:
21770
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.387
AC:
10121
AN:
26128
East Asian (EAS)
AF:
0.306
AC:
12153
AN:
39694
South Asian (SAS)
AF:
0.227
AC:
19582
AN:
86234
European-Finnish (FIN)
AF:
0.340
AC:
18181
AN:
53400
Middle Eastern (MID)
AF:
0.341
AC:
1967
AN:
5768
European-Non Finnish (NFE)
AF:
0.358
AC:
398195
AN:
1111758
Other (OTH)
AF:
0.349
AC:
21086
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
21436
42871
64307
85742
107178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12528
25056
37584
50112
62640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.321
AC:
48781
AN:
152080
Hom.:
8380
Cov.:
32
AF XY:
0.319
AC XY:
23692
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.203
AC:
8435
AN:
41488
American (AMR)
AF:
0.444
AC:
6795
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.389
AC:
1349
AN:
3466
East Asian (EAS)
AF:
0.315
AC:
1628
AN:
5164
South Asian (SAS)
AF:
0.227
AC:
1091
AN:
4814
European-Finnish (FIN)
AF:
0.329
AC:
3481
AN:
10586
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24962
AN:
67958
Other (OTH)
AF:
0.339
AC:
714
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1708
3416
5123
6831
8539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.354
Hom.:
47524
Bravo
AF:
0.324
TwinsUK
AF:
0.355
AC:
1316
ALSPAC
AF:
0.369
AC:
1423
ESP6500AA
AF:
0.198
AC:
871
ESP6500EA
AF:
0.365
AC:
3135
ExAC
AF:
0.339
AC:
41118
Asia WGS
AF:
0.252
AC:
878
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Curry-Hall syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.31
T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.0029
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
3.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.16
Sift
Benign
0.12
T
Sift4G
Benign
0.085
T
Polyphen
1.0
D
Vest4
0.20
ClinPred
0.018
T
GERP RS
4.1
Varity_R
0.097
gMVP
0.29
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1383180; hg19: chr4-5785442; COSMIC: COSV53832754; API